Published in Pers Soc Psychol Bull on October 01, 2005
Do Contact and Empathy Mitigate Bias Against Gay and Lesbian People Among Heterosexual First-Year Medical Students? A Report From the Medical Student CHANGE Study. Acad Med (2015) 2.74
Physicians' implicit and explicit attitudes about race by MD race, ethnicity, and gender. J Health Care Poor Underserved (2009) 2.38
Implicit cognition and addiction: a tool for explaining paradoxical behavior. Annu Rev Clin Psychol (2010) 2.26
Aversive Racism and Medical Interactions with Black Patients: A Field Study. J Exp Soc Psychol (2010) 2.05
Implicit and explicit weight bias in a national sample of 4,732 medical students: the medical student CHANGES study. Obesity (Silver Spring) (2014) 1.71
Racism and Health I: Pathways and Scientific Evidence. Am Behav Sci (2013) 1.57
The influence of implicit bias on treatment recommendations for 4 common pediatric conditions: pain, urinary tract infection, attention deficit hyperactivity disorder, and asthma. Am J Public Health (2012) 1.56
The mixed impact of medical school on medical students' implicit and explicit weight bias. Med Educ (2015) 1.46
Moderators of the relationship between implicit and explicit evaluation. J Exp Psychol Gen (2005) 1.41
Implicit social cognition: from measures to mechanisms. Trends Cogn Sci (2011) 1.41
Implicit and explicit anti-fat bias among a large sample of medical doctors by BMI, race/ethnicity and gender. PLoS One (2012) 1.33
Instrumentation issues in implementation science. Implement Sci (2014) 1.21
The relationship between nature connectedness and happiness: a meta-analysis. Front Psychol (2014) 1.07
Politics on the brain: an FMRI investigation. Soc Neurosci (2006) 1.06
Extending the Implicit Association Test (IAT): assessing consumer attitudes based on multi-dimensional implicit associations. PLoS One (2011) 1.04
The Intergenerational Transmission of Implicit and Explicit Attitudes Toward Smoking. J Exp Soc Psychol (2009) 1.03
Exposing racial discrimination: implicit & explicit measures--the My Body, My Story study of 1005 US-born black & white community health center members. PLoS One (2011) 1.02
Can antistigma campaigns be improved? A test of the impact of biogenetic vs psychosocial causal explanations on implicit and explicit attitudes to schizophrenia. Schizophr Bull (2007) 1.01
Capturing doping attitudes by self-report declarations and implicit assessment: a methodology study. Subst Abuse Treat Prev Policy (2008) 1.00
Underpowered samples, false negatives, and unconscious learning. Psychon Bull Rev (2016) 0.99
Implicit and explicit attitudes predict smoking cessation: moderating effects of experienced failure to control smoking and plans to quit. Psychol Addict Behav (2010) 0.96
Disgust and implicit self-concept in women with borderline personality disorder and posttraumatic stress disorder. Eur Arch Psychiatry Clin Neurosci (2010) 0.95
Illegal performance enhancing drugs and doping in sport: a picture-based brief implicit association test for measuring athletes' attitudes. Subst Abuse Treat Prev Policy (2014) 0.94
Do implicit attitudes predict actual voting behavior particularly for undecided voters? PLoS One (2012) 0.92
Drink refusal self-efficacy and implicit drinking identity: an evaluation of moderators of the relationship between self-awareness and drinking behavior. Addict Behav (2013) 0.92
Impulsivity, impulsive and reflective processes and the development of alcohol use and misuse in adolescents and young adults. Front Psychol (2010) 0.92
An Implicit Measure of Anti-Gay Attitudes: Prospective Associations with Emotion Regulation Strategies and Psychological Distress. J Exp Soc Psychol (2009) 0.91
Examining implicit bias of physicians who care for individuals with spinal cord injury: A pilot study and future directions. J Spinal Cord Med (2014) 0.91
Modulation of self-esteem in self- and other-evaluations primed by subliminal and supraliminal faces. PLoS One (2012) 0.88
A Smart Unconscious? Procedural Origins of Automatic Partner Attitudes in Marriage. J Exp Soc Psychol (2010) 0.87
Meta-analytic evidence of low convergence between implicit and explicit measures of the needs for achievement, affiliation, and power. Front Psychol (2014) 0.87
Automatically activated shame reactions and perceived legitimacy of discrimination: A longitudinal study among people with mental illness. J Behav Ther Exp Psychiatry (2009) 0.86
For better or worse? Stress inoculation effects for implicit but not explicit anxiety. Depress Anxiety (2009) 0.84
Dissociable effects of prefrontal and anterior temporal cortical lesions on stereotypical gender attitudes. Neuropsychologia (2009) 0.83
Understanding how adherence goals promote adherence behaviours: a repeated measure observational study with HIV seropositive patients. BMC Public Health (2012) 0.83
Characterizing implicit mental health associations across clinical domains. J Behav Ther Exp Psychiatry (2016) 0.83
Evaluative Conditioning: The "How" Question. Adv Exp Soc Psychol (2010) 0.82
Decisions among the undecided: implicit attitudes predict future voting behavior of undecided voters. PLoS One (2014) 0.82
Toward a comprehensive understanding of executive cognitive function in implicit racial bias. J Pers Soc Psychol (2015) 0.82
Racial bias in pain perception and response: experimental examination of automatic and deliberate processes. J Pain (2014) 0.82
Using the EZ-Diffusion Model to Score a Single-Category Implicit Association Test of Physical Activity. Psychol Sport Exerc (2015) 0.82
Patterns of implicit and explicit attitudes in children and adults: tests in the domain of religion. J Exp Psychol Gen (2012) 0.82
Associating versus proposing or associating what we propose: comment on Gawronski and Bodenhausen (2006). Psychol Bull (2006) 0.81
Sociality as a natural mechanism of public goods provision. PLoS One (2015) 0.81
Functional imaging of implicit marijuana associations during performance on an Implicit Association Test (IAT). Behav Brain Res (2013) 0.80
Affective compatibility between stimuli and response goals: a primer for a new implicit measure of attitudes. PLoS One (2013) 0.80
Implicit and explicit stigma of mental illness: attitudes in an evidence-based practice. J Nerv Ment Dis (2013) 0.79
Warmth and competence in your face! Visual encoding of stereotype content. Front Psychol (2013) 0.79
Awareness of implicit attitudes. J Exp Psychol Gen (2013) 0.78
Clinicians' Implicit and Explicit Attitudes about Weight and Race and Treatment Approaches to Overweight for American Indian Children. Child Obes (2015) 0.77
Explicit and Implicit Attitudes of Canadian Psychiatrists Toward People With Mental Illness. Can J Psychiatry (2015) 0.77
Explicit- and implicit bullying attitudes in relation to bullying behavior. J Abnorm Child Psychol (2010) 0.77
Feasibility and preliminary outcomes from a pilot study of an integrated health-mental health promotion program in school mental health services. Fam Community Health (2013) 0.77
Cerebral Correlates of Automatic Associations Towards Performance Enhancing Substances. Front Psychol (2015) 0.76
Overcoming Weight Bias in the Management of Patients With Diabetes and Obesity. Clin Diabetes (2016) 0.75
The Effects of Obesity-Related Health Messages on Explicit and Implicit Weight Bias. Front Psychol (2017) 0.75
The effects of racial attitudes on affect and engagement in racially discordant medical interactions between non-Black physicians and Black patients. Group Process Intergroup Relat (2016) 0.75
Social Dominance Orientation, Dispositional Empathy, and Need for Cognitive Closure Moderate the Impact of Empathy-Skills Training, but Not Patient Contact, on Medical Students' Negative Attitudes toward Higher-Weight Patients. Front Psychol (2017) 0.75
Neural Patterns of the Implicit Association Test. Front Hum Neurosci (2015) 0.75
On Feeling Torn About One's Sexuality: The Effects of Explicit-Implicit Sexual Orientation Ambivalence. Pers Soc Psychol Bull (2014) 0.75
Hooked on a feeling: affective anti-smoking messages are more effective than cognitive messages at changing implicit evaluations of smoking. Front Psychol (2015) 0.75
Neuroticism explains unwanted variance in Implicit Association Tests of personality: possible evidence for an affective valence confound. Front Psychol (2013) 0.75
Traditional Masculinity and Femininity: Validation of a New Scale Assessing Gender Roles. Front Psychol (2016) 0.75
Changing attitudes towards obesity - results from a survey experiment. BMC Public Health (2017) 0.75
The moderating role of internalized homonegativity on the efficacy of LGB-affirmative psychotherapy: Results from a randomized controlled trial with young adult gay and bisexual men. J Consult Clin Psychol (2016) 0.75
Feeling Happy and Sad at the Same Time? Subcultural Differences in Experiencing Mixed Emotions between Han Chinese and Mongolian Chinese. Front Psychol (2016) 0.75
Affective Priming by Eye Gaze Stimuli: Behavioral and Electrophysiological Evidence. Front Hum Neurosci (2016) 0.75
Macro-level implicit HIV prejudice and the health of community residents with HIV. Health Psychol (2016) 0.75
The Environment Makes a Difference: The Impact of Explicit and Implicit Attitudes as Precursors in Different Food Choice Tasks. Front Psychol (2016) 0.75
Intoxicated prejudice: The impact of alcohol consumption on implicitly and explicitly measured racial attitudes. Group Process Intergroup Relat (2015) 0.75
Narcissistic Traits and Explicit Self-Esteem: The Moderating Role of Implicit Self-View. Front Psychol (2016) 0.75
Think leader, think White? Capturing and weakening an implicit pro-White leadership bias. PLoS One (2014) 0.75
Implicit trust between the Uyghur and the Han in Xinjiang, China. PLoS One (2013) 0.75
Implicit versus Explicit Rejection Self-Perceptions and Adolescents' Interpersonal Functioning. Pers Individ Dif (2015) 0.75
Implicit Attitudes towards People with Intellectual Disabilities: Their Relationship with Explicit Attitudes, Social Distance, Emotions and Contact. PLoS One (2015) 0.75
Implicit attitudes in prosopagnosia. Neuropsychologia (2011) 0.75
Implicit and Explicit Self-Esteem in Current, Remitted, Recovered, and Comorbid Depression and Anxiety Disorders: The NESDA Study. PLoS One (2016) 0.75
Implicit affective associations predict snack choice for those with low, but not high levels of eating disorder symptomatology. Appetite (2014) 0.75
On the relationship between automatic attitudes and self-reported sexual assault in men. Arch Sex Behav (2012) 0.75
Behavioral Priming 2.0: Enter a Dynamical Systems Perspective. Front Psychol (2017) 0.75
Effects of Chocolate Deprivation on Implicit and Explicit Evaluation of Chocolate in High and Low Trait Chocolate Cravers. Front Psychol (2017) 0.75
Differences between tight and loose cultures: a 33-nation study. Science (2011) 3.47
Do psychosocial and study skill factors predict college outcomes? A meta-analysis. Psychol Bull (2004) 3.02
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol (2006) 2.48
Automatic mental associations predict future choices of undecided decision-makers. Science (2008) 2.46
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst (2002) 2.25
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Anticancer Drugs (2007) 2.08
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res (2002) 1.95
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Breast Cancer Res Treat (2008) 1.68
Ill-structured measurement designs in organizational research: implications for estimating interrater reliability. J Appl Psychol (2008) 1.59
Separating multiple processes in implicit social cognition: the quad model of implicit task performance. J Pers Soc Psychol (2005) 1.56
Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. J Proteome Res (2010) 1.48
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int J Oncol (2012) 1.44
Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int J Cancer (2002) 1.44
[Re: Kay Brune. Altex 19, 3, 2002: Animal experimentation in sciences: sadistic nonsense or indispensible necessity?]. ALTEX (2002) 1.40
Working memory capacity and self-regulatory behavior: toward an individual differences perspective on behavior determination by automatic versus controlled processes. J Pers Soc Psychol (2008) 1.38
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res (2005) 1.34
Deontological and utilitarian inclinations in moral decision making: a process dissociation approach. J Pers Soc Psychol (2012) 1.31
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. Clin Chem (2008) 1.31
Beyond alpha: an empirical examination of the effects of different sources of measurement error on reliability estimates for measures of individual differences constructs. Psychol Methods (2003) 1.24
Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol (2008) 1.19
Cognitive vulnerability to anxiety: A review and an integrative model. Clin Psychol Rev (2009) 1.18
Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer. Thromb Haemost (2004) 1.17
Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer. J Clin Oncol (2003) 1.14
Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem (2006) 1.13
The self-regulation of automatic associations and behavioral impulses. Psychol Rev (2008) 1.13
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Clin Cancer Res (2009) 1.12
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. Eur J Cancer (2005) 1.10
Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in a cohort of Caucasian individuals. Clin Cancer Res (2005) 1.09
DNA methylation as a biomarker in breast cancer. Future Oncol (2009) 1.09
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study. Breast Cancer Res Treat (2007) 1.09
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. Breast Cancer Res Treat (2007) 1.08
Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Anticancer Drugs (2008) 1.08
Low self-esteem is a risk factor for depressive symptoms from young adulthood to old age. J Abnorm Psychol (2009) 1.07
Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination. J Clin Oncol (2002) 1.07
At the boundaries of automaticity: negation as reflective operation. J Pers Soc Psychol (2006) 1.04
Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424). Cancer Res (2002) 1.04
Scanning-slit photon counting x-ray imaging system using a microchannel plate detector. Med Phys (2004) 1.04
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel. BMC Cancer (2011) 1.03
Intervention effects on college performance and retention as mediated by motivational, emotional, and social control factors: integrated meta-analytic path analyses. J Appl Psychol (2009) 1.03
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Res (2014) 1.02
Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease. Cancer Res (2004) 1.01
Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction. Biol Chem (2003) 1.01
Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1. Thromb Haemost (2005) 1.01
Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value. J Craniomaxillofac Surg (2005) 1.01
Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. Clin Breast Cancer (2004) 1.00
Integrated molecular portrait of non-small cell lung cancers. BMC Med Genomics (2013) 0.99
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7. Biol Chem (2008) 0.99
The development of spontaneous gender stereotyping in childhood: relations to stereotype knowledge and stereotype flexibility. Dev Sci (2010) 0.98
Implications of direct and indirect range restriction for meta-analysis methods and findings. J Appl Psychol (2006) 0.98
Tumor markers: from laboratory to clinical utility. Mol Cell Proteomics (2003) 0.97
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res (2003) 0.97
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer. Eur J Nucl Med Mol Imaging (2007) 0.96
CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients. BMC Cancer (2010) 0.96
Detailed analysis of five mutations in dihydropyrimidine dehydrogenase detected in cancer patients with 5-fluorouracil-related side effects. Hum Mutat (2003) 0.96
Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation. Exp Cell Res (2009) 0.95
Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Biol Chem (2003) 0.94
Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor. Breast Cancer Res Treat (2007) 0.94
Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res (2003) 0.93
Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo. Curr Pharm Des (2003) 0.93
Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer. Thromb Haemost (2003) 0.93
High hydrostatic pressure, a novel approach in orthopedic surgical oncology to disinfect bone, tendons and cartilage. Anticancer Res (2009) 0.93
Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria. J Pathol (2013) 0.92
High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread. FEBS Lett (2002) 0.92
Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients. Biol Chem (2012) 0.92
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin Cancer Res (2006) 0.92
Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells. Mol Cancer Res (2013) 0.92
Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Rev Mol Diagn (2010) 0.92
ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. Int J Biochem Cell Biol (2005) 0.92
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer. Breast Cancer Res (2012) 0.92
De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry. J Pathol (2014) 0.91
Intrathecal trastuzumab: dose matters. Acta Oncol (2012) 0.91
Selective exposure in decided and undecided individuals: differential relations to automatic associations and conscious beliefs. Pers Soc Psychol Bull (2012) 0.91
Immunohistochemical demonstration of the zinc metalloprotease insulin-degrading enzyme in normal and malignant human breast: correlation with tissue insulin levels. Int J Oncol (2007) 0.90
The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochem J (2008) 0.90
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis. Tumour Biol (2004) 0.89
Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR). Biol Chem (2006) 0.89
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients. Clin Biochem (2004) 0.89
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Int J Mol Med (2008) 0.89
Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer. Biol Chem (2010) 0.88
Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy. J Clin Oncol (2009) 0.88
Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells. Mol Cancer (2012) 0.88
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy. Breast Cancer Res Treat (2008) 0.87
Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients. Thromb Haemost (2003) 0.87
Interventions against norm violations: dispositional determinants of self-reported and real moral courage. Pers Soc Psychol Bull (2013) 0.87
Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription. J Cell Physiol (2009) 0.87
Estimation of coronary artery hyperemic blood flow based on arterial lumen volume using angiographic images. Int J Cardiovasc Imaging (2011) 0.86
Synthesis, solution structure, and biological evaluation of urokinase type plasminogen activator (uPA)-derived receptor binding domain mimetics. J Med Chem (2002) 0.86
Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo. Breast Cancer Res Treat (2010) 0.86
Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: an EORTC-NCI working group report. Int J Oncol (2003) 0.86
Effect of high hydrostatic pressure on biological properties of extracellular bone matrix proteins. Int J Mol Med (2005) 0.86
Biomechanical and immunohistochemical analysis of high hydrostatic pressure-treated Achilles tendons. J Orthop Sci (2006) 0.85
Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients. Clin Cancer Res (2007) 0.85
Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues. Int J Mol Med (2008) 0.85
Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms. Crit Rev Clin Lab Sci (2007) 0.84
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker. J Clin Oncol (2004) 0.84
Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer. Biol Chem (2014) 0.84
Effect of extracorporeal high hydrostatic pressure on cellular outgrowth from tumor-afflicted bone. Anticancer Res (2006) 0.84
Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts. Clin Breast Cancer (2002) 0.83